Sofgen Pharma S.A. (PROCF)

Market Cap	256.00M -13.1%
Revenue (ttm)	373.80M -8.5%
Net Income	-68.30M
EPS	-0.68
Shares Out	2.33B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,100
Average Volume	1,069
Open	0.0326
Previous Close	0.0011
Day's Range	0.0326 - 0.1100
52-Week Range	0.0011 - 1.4700
Beta	64.78
RSI	47.55
Earnings Date	May 15, 2026

About Sofgen Pharma

Sofgen Pharma S.A., together with its subsidiaries, develops, produces, and markets pharmaceutical solutions in South America, Central America, North America, and Europe. It operates in five segments: NextGel, Procaps Colombia, Central America North (CAN), Central America South and North Andes (CASAND), and Diabetrics. The company develops and manufactures Softgel and related technologies under the Softigel, Sofgen, Softcaps, and Funtrition brands; and Softgel pharmaceutical products, such as Advil, Apronax Liquidgels, multivitamins, Vitamin D,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1977
• Employees: 5,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: PROCF